1. Home
  2. DRD vs SYRE Comparison

DRD vs SYRE Comparison

Compare DRD & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DRDGOLD Limited

DRD

DRDGOLD Limited

N/A

Current Price

$32.83

Market Cap

3.4B

ML Signal

N/A

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

N/A

Current Price

$41.49

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DRD
SYRE
Founded
1895
2013
Country
South Africa
United States
Employees
3410
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.6B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
DRD
SYRE
Price
$32.83
$41.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$32.63
$55.57
AVG Volume (30 Days)
272.0K
680.5K
Earning Date
01-01-0001
05-19-2026
Dividend Yield
1.81%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$34.35
N/A
Revenue Next Year
$24.62
N/A
P/E Ratio
$15.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.08
$10.91
52 Week High
$39.37
$45.76

Technical Indicators

Market Signals
Indicator
DRD
SYRE
Relative Strength Index (RSI) 43.87 61.24
Support Level $32.20 $15.01
Resistance Level $34.06 $45.76
Average True Range (ATR) 1.41 2.33
MACD -0.41 -0.28
Stochastic Oscillator 17.68 47.86

Price Performance

Historical Comparison
DRD
SYRE

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: